Release date: 12/15/2022
Expiration date: 12/15/2023
Program Overview: A non-accredited educational activity to summarize the current treatment options for pulmonary artery disease.
Target Audience: Cardiologists, pulmonologists, nurse practitioners, physician assistants, nurses and other providers involved in the management of patients with pulmonary arterial hypertension (PAH)
Learning Objective:
Summarize current treatment options for pulmonary arterial hypertension.
Faculty:
Deborah C. Clark, PhD Senior Director of Professional Development
Commercial Support:
Supported by an educational grant from Merck Sharp & Dohme LLC a subsidiary of Merck & Co., Inc.
